Importance of Margins, Radiotherapy, and Systemic Therapy in Mucosal Melanoma of the Head and Neck

被引:11
作者
Sahovaler, Axel [1 ]
Ziai, Hedyeh [1 ]
Cardemil, Felipe [1 ]
Huang, Shao Hui [1 ,2 ]
Su, Jie [3 ]
Goldstein, David P. [1 ]
Gilbert, Ralph [1 ]
Hosni, Ali [2 ]
Hope, Andrew [2 ]
Waldron, John [1 ,2 ]
Spreafico, Anna [4 ]
Monteiro, Eric [5 ]
Witterick, Ian [5 ]
Irish, Jonathan [1 ]
Gullane, Patrick [1 ]
Xu, Wei [3 ]
O'Sullivan, Brian [1 ,2 ]
de Almeida, John R. [1 ]
机构
[1] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Univ Toronto, Dept Radiat Oncol, Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] Univ Toronto, Dept Biostat, Princess Margaret Canc Ctr, Toronto, ON, Canada
[4] Univ Toronto, Div Med Oncol & Hematol, Princess Margaret Canc Ctr, Toronto, ON, Canada
[5] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Sinai Hlth Syst, Toronto, ON, Canada
关键词
Mucosal melanoma; surgery; radiotherapy; systemic therapy; immunotherapy;
D O I
10.1002/lary.29555
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives/Hypothesis The ideal strategy in the treatment of mucosal melanoma of the head and neck (MMHN) remains unclear. Our objective was to evaluate the importance of surgical margins, radiotherapy, and systemic therapy in MMHN. Study Design Retrospective Single Institutional Review. Methods Retrospective review of patients with MMHN treated at a tertiary care oncology center between 1999 and 2016. Results Seventy-six patients were included, 60 of whom were treated with curative intent. Negative or close margins compared with positive margins were associated with higher 3-year overall survival (OS) (62% vs. 29% vs. 13% P = .012), disease-free survival (33% vs. 29% vs. 4% P = .003), and distant control (48% vs. 29% vs. 22% P = .039). Cases with pre-/postoperative radiotherapy had a marginally higher locoregional control versus without (69% vs. 59%, P = .117). Immunotherapy for recurrent and/or metastatic disease was associated with an increase in 3-year OS (15% vs. 3% P = .01). Conclusion Achieving negative surgical margins is relevant in disease control. Despite small sample size, our data suggest that radiotherapy may enhance surgical outcomes. Immunotherapy has therapeutic benefit. Level of Evidence 3 Laryngoscope, 2021
引用
收藏
页码:2269 / 2276
页数:8
相关论文
共 42 条
  • [1] Role of adjuvant chemotherapy in malignant mucosal melanoma of the head and neck
    Ahn, Heui June
    Na, Im Il
    Park, Yeon Hee
    Cho, Soo Youn
    Lee, Byeong Cheol
    Lee, Guk Haeng
    Koh, Jae Soo
    Lee, Yong Sik
    Shim, Yoon Sang
    Kim, Yong Kack
    Kang, Hye Jin
    Ryoo, Baek-Yeol
    Yang, Sung Hyun
    [J]. ORAL ONCOLOGY, 2010, 46 (08) : 607 - 611
  • [2] Amin MB, 2017, AJCC cancer staging manual, Veighth
  • [3] ASO Author Reflections: Treatment Approaches to Sinonasal Mucosal Melanoma
    Amit, Moran
    Hanna, Ehab Y.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 890 - 891
  • [4] Contemporary Treatment Approaches to Sinonasal Mucosal Melanoma
    Amit, Moran
    Na'ara, Shorook
    Hanna, Ehab Y.
    [J]. CURRENT ONCOLOGY REPORTS, 2018, 20 (02)
  • [5] Role of Adjuvant Treatment in Sinonasal Mucosal Melanoma
    Amit, Moran
    Tam, Samantha
    Abdelmeguid, Ahmed S.
    Kupferman, Michael E.
    Su, Shirley Y.
    Raza, Shaan M.
    DeMonte, Franco
    Hanna, Ehab Y.
    [J]. JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 2017, 78 (06) : 512 - 518
  • [6] Mucosal melanomas of the head and neck: The Princess Margaret Hospital experience
    Bachar, Gideon
    Loh, Kwok Seng
    O'Sullivan, Brian
    Goldstein, David
    Wood, Stephen
    Brown, Dale
    Irish, Jonathan
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2008, 30 (10): : 1325 - 1331
  • [7] Adjuvant radiotherapy in sinonasal mucosal melanoma: A retrospective analysis
    Caspers, C. J. I.
    Dronkers, E. A. C.
    Monserez, D.
    Wieringa, M. H.
    de Jong, R. J. Baatenburg
    Hardillo, J. A. U.
    [J]. CLINICAL OTOLARYNGOLOGY, 2018, 43 (02) : 617 - 623
  • [8] Chang AE, 1998, CANCER, V83, P1664, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO
  • [9] 2-G
  • [10] Adjuvant radiotherapy for cutaneous melanoma: Comparing hypofractionation to conventional fractionation
    Chang, Daniel T.
    Amdur, Robert J.
    Morris, Christopher G.
    Mendenhall, William M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (04): : 1051 - 1055